Umbilical cord blood for cardiovascular cell therapy: From promise to fact

Annals of the New York Academy of Sciences

Volumn 1254, Issue 1, 2012, Pages 66-70

  Roura, Santiago ^a   Pujal, Josep Maria ^a   Bayes Genis, Antoni ^a,b,c,d  

^a FUNDACIÓ INSTITUT D INVESTIGACIÓ EN CIÈNCIES DE LA SALUT GERMANS TRIAS I PUJOL   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

Author keywords

Cardiovascular diseases; Mesenchymal stem cell; Umbilical cord blood

Indexed keywords

ARTICLE; AUTISM; BEHCET DISEASE; BIOLUMINESCENCE; BRAIN ISCHEMIA; CAPILLARY DENSITY; CARDIOVASCULAR CELL THERAPY; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL EXPANSION; CELL LINEAGE; CELL LOSS; CELL THERAPY; CELL VIABILITY; CEREBRAL PALSY; CONFOCAL MICROSCOPY; DISEASE SEVERITY; ENDOTHELIUM CELL; EXPRESSION VECTOR; GRAFT VERSUS HOST REACTION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEMATOLOGIC DISEASE; HLA MATCHING; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MICROVASCULATURE; NEONATAL ISCHEMIC ENCEPHALOPATHY; STEM CELL; UMBILICAL CORD BLOOD;

EID: 84860476170     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2012.06515.x     Document Type: Article

References (48)

1. Drexler, H. & B. Hornig 1999. Endothelial dysfunction in human disease. J. Mol. Cell Cardiol. 31: 51-60.
2. Kumar, A.H. & N.M. Caplice 2010. Clinical potential of adult vascular progenitor cells. Arterioscler.ThrombVasc. Biol. 30: 1080-1087.
3. Oswald, J. et al 2004. Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 22: 377-384.
4. Schmeckpeper, J. et al 2009. Lentiviral tracking of vascular differentiation in bone marrow progenitor cells. Differentiation 78: 169-176.
5. Heydarkhan-Hagvall, S. et al 2008. Human adipose stem cells: a potential cell source for cardiovascular tissue engineering. Cells Tissues Organs 187: 263-274.
6. Gluckman, E. 2011. Milestones in umbilical cord blood transplantation. Blood Rev. 25: 255-259.
7. Liao, Y. et al 2011. Cord blood transplantation and stem cell regenerative potential. Exp. Hematol. 39: 393-412.
8. Barker, J.N. & J.E. Wagner 2003. Umbilical-cord blood transplantation for the treatment of cancer. Nat. Rev. Cancer 3: 526-532.
9. Riordan, N.H. et al 2007. Cord blood in regenerative medicine: do we need immune suppression? J. Transl. Med. 5: 8.
10. Knutsen, A.P. & D.A. Wall 2000. Umbilical cord blood transplantation in severe T-cell immunodeficiency disorders: two-year experience. J. ClinImmunol. 20: 466-476.
11. Jaing, T.H. et al 2005. Successful unrelated cord blood transplantation in a child with beta-thalassemia major. J. Trop. Pediatr. 51: 122-124.
12. Nishino, T. et al 2011. Ex vivo expansion of human hematopoietic stem cells by garcinol, a potent inhibitor of histone acetyltransferase. PLoS One 6: e24298.
13. Neokleous, N., A. Sideri & C. Peste-Tsilimidos 2011. Double cord blood transplantation: co-operation or competition? Hematol. Rep. 3: e6.
14. Chen, Y.B. et al 2011. Reduced-intensity conditioning stem cell transplantation: comparison of double umbilical cord blood and unrelated donor grafts. Biol. Blood Marrow Transplant. doi:
15. Ramirez, P. et al 2011. Factors predicting single-unit predominance after double umbilical cord blood transplantation. Bone Marrow Transpl. doi:
16. Lavergne, M. et al 2011. Cord blood-circulating endothelial progenitors for treatment of vascular diseases. Cell Prolif. 44: 44-47.
17. Tomonari, A. et al 2004. Resolution of Behçet's disease after HLA-mismatched unrelated cord blood transplantation for myelodysplastic syndrome. Ann. Hematol. 83: 464-466.
18. Ichim, T.E. et al 2007. Stem cell therapy for autism. J. Transl. Med. 5: 30.
19. Hu, C.H. et al 2006. Transplanted human umbilical cord blood mononuclear cells improve left ventricular function through angiogenesis in myocardial infarction. Chin Med. J. (Engl). 119: 1499-1506.
20. + cells enhance function and repair of the infarcted myocardium. Stem Cells 24: 772-780.
21. Newcomb, J.D. et al 2006. Timing of cord blood treatment after experimental stroke determines therapeutic efficacy. Cell Transpl. 15: 213-223.
22. Liao, W. et al 2009. Therapeutic benefit of human umbilical cord derived mesenchymal stromal cells in intracerebral hemorrhage rat: implications of anti-inflammation and angiogenesis. Cell Physiol. Biochem. 24: 307-316.
23. Pittenger, M.F. & B.J. Martin 2004. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ. Res. 95: 9-20.
24. Zuk, P.A. et al 2002. Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell. 13: 4279-4295.
25. Parolini, O. et al 2008. Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells 26: 300-311.
26. Hsiao, S.T. et al 2012. Comparative analysis of paracrine factor expression in human adult mesenchymal stem cells derived from bone marrow, adipose and dermal tissue. Stem Cells Dev. doi:
27. Kadivar, M. et al 2006. In vitro cardiomyogenic potential of human umbilical vein-derived mesenchymal stem cells. Biochem. Biophys. Res. Commun. 340: 639-647.
28. Kogler, G. et al 2004. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J. Exp. Med. 200: 123-135.
29. Manca, M.F. et al 2008. Characterization of mesenchymal stromal cells derived from full-term umbilical cord blood. Cytotherapy 10: 54-68.
30. Prat-Vidal, C. et al 2007. Umbilical cord blood-derived stem cells spontaneously express cardiomyogenic traits. Transplant Proc. 239: 2434-2437.
31. Nishiyama, N. et al 2007. The significant cardiomyogenic potential of human umbilical cord blood-derived mesenchymal stem cells in vitro. Stem Cells 25: 2017-2024.
32. Roura, S. et al 2010. Exposure to cardiomyogenic stimuli fails to transdifferentiate human umbilical cord blood-derived mesenchymal stem cells. Basic Res. Cardiol. 105: 419-430.
33. + mesenchymal stem cells. Eur. J. Heart Fail. 8: 555-563.
34. Nakamura, T. et al 2003. A Wnt- and beta-catenin-dependent pathway for mammalian cardiac myogenesis. Proc. Natl. Acad. Sci. USA 100: 5834-5839.
35. Bartunek, J. et al 2007. Pretreatment of adult bone marrow mesenchymal stem cells with cardiomyogenic growth factors and repair of the chronically infarcted myocardium. Am. J. Physiol. Heart Circ. Physiol. 292: H1095-H1104
36. Koyanagi, M. et al 2005. Non-canonical Wnt signaling enhances differentiation of human circulating progenitor cells to cardiomyogenic cells. J. Biol. Chem. 280: 16838-16842.
37. Badorff, C. et al 2003. Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation 107: 1024-1032.
38. Bayes-Genis, A. et al 2010. Human progenitor cells derived from cardiac adipose tissue ameliorate myocardial infarction in rodents. J. Mol. Cell Cardiol. 49: 771-780.
39. Park, J. et al 2009. Umbilical cord blood stem cells: induction of differentiation into mesenchymal lineages by cell-cell contacts with various mesenchymal cells. Tissue Eng. Part A 15: 397-406.
40. (+) cells into a Cardiomyocyte-like phenotype. Stem Cell Rev. doi:
41. Zwart, I. et al 2008. Analysis of neural potential of human umbilical cord blood-derived multipotent mesenchymal stem cells in response to a range of neurogenic stimuli. J. Neurosci. Res. 86: 1902-1915.
42. Hill, A.J. et al 2009. Human umbilical cord blood-derived mesenchymal stem cells do not differentiate into neural cells types or integrate into the retina after intravitreal grafting in neonatal rats. Stem Cells Dev. 18: 399-409.
43. Ma, N. et al 2005. Human cord blood cells induce angiogenesis following myocardial infarction in NOD/scid-mice. Cardiovasc. Res. 66: 45-54.
44. Almendro, N. et al 1996. Cloning of the human platelet endothelial cell adhesion molecule-1 promoter and its tissue-specific expression. Structural and functional characterization. J. Immunol. 157: 5411-5421.
45. Ichim, T.E. et al 2008. Placental mesenchymal and cord blood stem cell therapy for dilated cardiomyopathy. Reprod. Biomed. Online 16: 898-905.
46. Roura, S. et al 2007. Idiopathic dilated cardiomyopathy exhibits defective vascularization and vessel formation. Eur. J. Heart Fail. 9: 995-1002.
47. Roura, S. & A. Bayes-Genis 2009. Vascular dysfunction in idiopathic dilated cardiomyopathy. Nat. Rev. Cardiol. 6: 590-598.
48. Pujal, J.M. et al 2012. Fetal-maternal interface: a chronicle of allogeneic coexistence. Chimerism 3, In press.